Development of a psilocin immunoassay for serum and blood samples

Int J Legal Med. 2004 Dec;118(6):326-31. doi: 10.1007/s00414-004-0469-9. Epub 2004 Aug 3.

Abstract

After the immunisation of rabbits with a psilocin-specific immunogen, polyclonal antisera were obtained. With these antisera a competitive, heterogeneous radioimmunoassay for the detection of psilocin was developed. As tracer a derivative of psilocin was synthesised, which contained a tritiated CH(3) group. The antisera showed a specific reaction with psilocin. The cross-reactivity of structurally related endogenous substances like serotonin, tryptophan and tyrosine was below 0.01%. Also common drugs of abuse (Delta(9)-tetrahydrocannabinol, cocaine, morphine, amphetamine) showed negligible cross-reactivity (0.01-2%). Only tricyclic neuroleptics with a (dimethylamino)ethyl side-chain showed some cross-reactivity (20%). Spiked serum and blood samples were analysed with this new immunoassay and the results obtained were compared with the values measured with a validated GC-MS method.

Publication types

  • Evaluation Study

MeSH terms

  • Animals
  • Hallucinogens / blood*
  • Humans
  • Psilocybin / analogs & derivatives*
  • Psilocybin / blood*
  • Rabbits
  • Radioimmunoassay / methods*
  • Sensitivity and Specificity
  • Substance Abuse Detection / methods*

Substances

  • Hallucinogens
  • Psilocybin
  • psilocin